Cost comparison of post-remission strategies in younger and older AML patients in France

被引：0
|
作者：
Michael Mounie
Pierre-Yves Dumas
Sandra Liva-Yonnet
Didier Fabre
Thibault Leguay
Jean Galtier
Emilie Berard
Ramaroson Hanta
Véronique Gilleron
Sarah Bertoli
Arnaud Pigneux
Christian Récher
Nadège Costa
机构：
[1] Centre Hospitalier Universitaire (CHU),Unité d’Evaluation Médico
[2] Institut National de la Santé et de la Recherche Médicale,Economique
[3] CHU Bordeaux,Département d’Information Médicale
[4] Service d’Hématologie Clinique et de Thérapie Cellulaire,Service d’Hématologie, Centre Hospitalier Universitaire de Toulouse
[5] Université de Bordeaux,Cancer Research Center of Toulouse, Unité Mixte de Recherche (UMR) 1037 INSERM
[6] Institut National de la Santé et de la Recherche Médicale,undefined
[7] Centre Hospitalier Universitaire (CHU),undefined
[8] Département d’Information Médicale,undefined
[9] Centre Hospitalier Universitaire (CHU),undefined
[10] Institut Universitaire du Cancer de Toulouse Oncopole,undefined
[11] Université Toulouse III Paul Sabatier,undefined
[12] ERL5294 Centre National de la Recherche Scientifique,undefined
来源：
Blood Cancer Journal | / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cost comparison of post-remission strategies in younger and older AML patients in France
    Mounie, Michael
    Dumas, Pierre-Yves
    Liva-Yonnet, Sandra
    Fabre, Didier
    Leguay, Thibault
    Galtier, Jean
    Berard, Emilie
    Hanta, Ramaroson
    Gilleron, Veronique
    Bertoli, Sarah
    Pigneux, Arnaud
    Recher, Christian
    Costa, Nadege
    [J]. BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [2] Should older adults with AML receive post-remission therapy?
    Stone, Richard M.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2015, 28 (2-3) : 106 - 111
  • [3] Optimal post-remission consolidation therapy in patients with AML
    Jimenez-Chillon, Carlos
    Dillon, Richard
    Russell, Nigel
    [J]. ACTA HAEMATOLOGICA, 2024, 147 (02) : 148 - 159
  • [4] Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?
    Foran, James M.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (04) : 306 - 311
  • [5] A MARKOV DECISION ANALYSIS OF POST-REMISSION STRATEGIES IN 2029 PATIENTS WITH AML IN FIRST REMISSION (CR1)
    Kurosawa, S.
    Yamaguchi, T.
    Miyawaki, S.
    Uchida, N.
    Kanamori, H.
    Usuki, K.
    Yamashita, T.
    Watanabe, M.
    Yakushiji, K.
    Yano, S.
    Nawa, Y.
    Miura, I.
    Kanda, Y.
    Takaue, Y.
    Fukuda, T.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S161 - S161
  • [6] The Value of Post-Remission Therapy in Older Adults with Acute Myeloid Leukemia (AML).
    Sekeres, Mikkael A.
    Fu, Alex Z.
    Earl, Marc
    Kalaycio, Matt
    Advani, Anjali
    Saunthararajah, Yogen
    Sobecks, Ronald
    Copelan, Edward
    [J]. BLOOD, 2009, 114 (22) : 431 - 432
  • [7] Time to Count Recovery after Post-Remission Chemotherapy in AML Patients
    Paras, Gabrielle
    Othus, Megan
    Shaw, Carole M.
    Russell, Katie
    Halpern, Anna B.
    Appelbaum, Jacob S.
    Hendrie, Paul C.
    Walter, Roland B.
    Percival, Mary-Elizabeth M.
    [J]. BLOOD, 2022, 140 : 6080 - 6081
  • [8] Retrospective analysis of post-remission modalities in AML patients with normal karyotype
    Chae, Yee Soo
    Sohn, Sang Kyun
    Kim, Jong Gwang
    Cho, Yoon Young
    Moon, Joon Ho
    Ahn, Byung Min
    Kim, Shi Nae
    [J]. BLOOD, 2007, 110 (11) : 132B - 132B
  • [9] BIOMARKER BASED POST-REMISSION STRATEGY IMPROVES THE OUTCOME OF ADULT AML PATIENTS
    Di Veroli, A.
    Buccisano, F.
    Maurillo, L.
    Piciocchi, A.
    Picardi, A.
    Cerretti, R.
    Del Principe, M. I.
    De Bellis, E.
    De Angelis, G.
    Cudillo, L.
    Cicconi, L.
    Rossi, V.
    Voso, M. T.
    Lo Coco, F.
    Amadori, S.
    Arcese, W.
    Venditti, A.
    [J]. HAEMATOLOGICA, 2017, 102 : 70 - 70
  • [10] The role of post-remission chemotherapy for older patients with acute myelogenous leukemia
    Abou-Jawde, RM
    Sobecks, R
    Pohlman, B
    Rybicki, L
    Advani, A
    Sekeres, M
    Kalaycio, M
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (04) : 689 - 695
12345